These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11346192)

  • 21. Olanzapine-induced elevation of plasma triglyceride levels.
    Sheitman BB; Bird PM; Binz W; Akinli L; Sanchez C
    Am J Psychiatry; 1999 Sep; 156(9):1471-2. PubMed ID: 10484969
    [No Abstract]   [Full Text] [Related]  

  • 22. The relationship of changes in leptin, neuropeptide Y and reproductive hormones to antipsychotic induced weight gain.
    Fitzgerald PB; Scaffidi A; Morris MJ; de Castella AR; Kulkarni J
    Hum Psychopharmacol; 2003 Oct; 18(7):551-7. PubMed ID: 14533137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of an educational intervention on antipsychotic-induced weight gain.
    Littrell KH; Hilligoss NM; Kirshner CD; Petty RG; Johnson CG
    J Nurs Scholarsh; 2003; 35(3):237-41. PubMed ID: 14562491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Randomized, open label study on the use of ranitidine at different doses for the management of weight gain associated with olanzapine administration].
    López-Mato A; Rovner J; Illa G; Vieitez A; Boullosa O
    Vertex; 2003; 14(52):85-96. PubMed ID: 12883589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risperidone side effects.
    Conley RR
    J Clin Psychiatry; 2000; 61 Suppl 8():20-3; discussion 24-5. PubMed ID: 10811239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel antipsychotics: comparison of weight gain liabilities.
    Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
    J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A program for treating olanzapine-related weight gain.
    Ball MP; Coons VB; Buchanan RW
    Psychiatr Serv; 2001 Jul; 52(7):967-9. PubMed ID: 11433117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
    Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
    J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re: Weight change with antipsychotic use.
    Dewan VK
    Can J Psychiatry; 2001 Sep; 46(7):660. PubMed ID: 11582832
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
    BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic-induced weight gain: bipolar disorder and leptin.
    McIntyre RS; Mancini DA; Basile VS; Srinivasan J; Kennedy SH
    J Clin Psychopharmacol; 2003 Aug; 23(4):323-7. PubMed ID: 12920406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative weight gain among antipsychotics.
    Masand PS
    J Clin Psychiatry; 1999 Oct; 60(10):706-8. PubMed ID: 10549690
    [No Abstract]   [Full Text] [Related]  

  • 35. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR; Mahmoud R
    Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A program for managing weight gain associated with atypical antipsychotics.
    Vreeland B; Minsky S; Menza M; Rigassio Radler D; Roemheld-Hamm B; Stern R
    Psychiatr Serv; 2003 Aug; 54(8):1155-7. PubMed ID: 12883145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
    Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
    Rosenheck R; Perlick D; Bingham S; Liu-Mares W; Collins J; Warren S; Leslie D; Allan E; Campbell EC; Caroff S; Corwin J; Davis L; Douyon R; Dunn L; Evans D; Frecska E; Grabowski J; Graeber D; Herz L; Kwon K; Lawson W; Mena F; Sheikh J; Smelson D; Smith-Gamble V;
    JAMA; 2003 Nov; 290(20):2693-702. PubMed ID: 14645311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olanzapine: weight gain and therapeutic efficacy.
    Gupta S; Droney T; Al-Samarrai S; Keller P; Frank B
    J Clin Psychopharmacol; 1999 Jun; 19(3):273-5. PubMed ID: 10350036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.